author-photo

Frank I. Lin

National Institutes of Health

50

Papers

695

Citations

Citation Trend

Filter By

Papers (35) Sort By

Journal Conference Others

High-specific-activity 131I-MIBG vs 177Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma.

2021 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (3)
Imaging of Pheochromocytoma and Paraganglioma.

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (3)
National Cancer Institute support for targeted alpha-emitter therapy.

2021 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (0)
Phase 1 study of Z-endoxifen in patients with advanced gynecologic, desmoid, and hormone receptor-positive solid tumors.

2021 Oncotarget
Show All
- Source
- Cite
- Save
Citations (2)
Case Report: Primary Hypothyroidism Associated With Lutetium 177-DOTATATE Therapy for Metastatic Paraganglioma

2021 Frontiers in Endocrinology
Show All
- Source
- Cite
- Save
Citations (0)
In Vitro and In Vivo Comparison of 3,2-HOPO Versus Deferoxamine-Based Chelation of Zirconium-89 to the Antimesothelin Antibody Anetumab.

2021 Cancer Biotherapy and Radiopharmaceuticals
Show All
- Source
- Cite
- Save
Citations (1)
Why bother with alpha particles

2021 European Journal of Nuclear Medicine and Molecular Imaging
Show All
- Source
- Cite
- Save
Citations (1)
Lutetium-177 DOTATATE Therapy Is Associated With Biochemical Endocrine Abnormalities in the Immediate Post-Treatment Period

2021 Journal of the Endocrine Society
Show All
- Source
- Cite
- Save
Citations (0)
A comparison of 18F-DCFPyL, 18F-NaF and 18F-FDG PET/CT in a prospective cohort of men with metastatic prostate cancer.

2021 The Journal of Nuclear Medicine
Show All
- Source
- Cite
- Save
Citations (0)
Competitive Blocking of Salivary Gland [18F]DCFPyL Uptake via Localized, Retrograde Ductal Injection of Non-radioactive DCFPyL: A Preclinical Study

2021
Show All
- Source
- Cite
- Save
Citations (0)